Current status of screening mammography

Obstetrics and Gynecology Clinics of North America

Volumn 29, Issue 1, 2002, Pages 123-136

  Feig, Stephen A ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH PROMOTION; HUMAN; MAMMOGRAPHY; META ANALYSIS; PRIORITY JOURNAL; RADIATION HAZARD; RISK BENEFIT ANALYSIS;

EID: 0036187857     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(03)00057-3     Document Type: Conference Paper

References (65)

1. 14 Years of follow-up from Edinburgh randomized trial of breast cancer screening
2. Reduced breast cancer mortality in women under 50: Updated results from the Malmo Mammographic Screening Program
3. Randomization in the Canadian national breast screening study: A review of evidence for subversion
4. Canadian national breast screening study: Assessment of technical quality by external review
5. The review of randomization in the Canadian national breast screening study: Is the debate over?
6. A critical appraisal of the Canadian national breast screening study
7. The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization
8. Cancer of the uterine cervix
9. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial
10. Issues in breast cancer screening in older women
11. The comparative value of mammographic screening for women 40-49 years of age versus women 50-64 years of age
12. Markov models of breast tumor progression: Some age-specific results
13. The effectiveness of breast cancer screening in younger women
14. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in patients older and younger than 50 years of age
15. Falun meeting on breast cancer screening with mammography in women aged 40-49 years: Report of the organizing committee and collaborators
16. Clinical efficacy of mammographic screening in the elderly
17. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years
18. Mammographic screening of women age 40-49: Benefit, risk, and cost considerations
19. Mammographic screening of elderly women
20. Methods to identify benefit from mammographic screening
21. Increased benefit from shorter screening mammography intervals for women ages 40-49 years
22. Age-related accuracy of screening mammography: How should it be measured?
23. Ductal carcinoma in situ: Implications for screening mammography
24. Clinical significance of ductal carcinoma in situ of the breast
25. Projected benefits and national health care costs from screening mammography
26. American college of radiology guidelines for breast cancer screening
27. Radiation risk from screening mammography of women aged 40-49 years
28. Report of the international workshop on screening for breast cancer
29. Mammographic screening trials for women aged under 50: A quality assessment and meta-analysis
30. Dedicated mammography x-ray equipment, screen-film processing-systems, and viewing conditions for mammography
31. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials
32. The benefits and risks of mammographic screening for breast cancer
33. Positive predictive value of screening mammography by age and family history of breast cancer
34. Efficacy of screening mammography: A meta-analysis
35. The Canadian screening program: A different perspective
36. The Canadian national breast screening study: A critical review
37. Positive predictive value of breast biopsy performed as a result of mammography: There is no abrupt change at age 50 years
38. Biasing the interpretation of mammography screening data by age grouping: Nothing changes abruptly at age 50
39. American cancer society guidelines for the early detection of breast cancer: Update
40. Mammography outcomes in a practice setting by age: Prognostic factors, sensitivity, and positive biopsy rate
41. Breast cancer screening for elderly women with and without comorbid conditions
42. The Canadian national breast screening study: An appraisal and implications for early detection policy
43. Breast cancer computer simulation method for estimation of optimal intervals for screening
44. Canadian national breast screening study. I. Breast cancer detection and death rates among women aged 40-49 years
45. Breast cancer: Age specific growth rates and screening strategies
46. Current approaches to cervical cancer screening
47. Auditing your practice
48. Benefit of mammography screening in women ages 40-49 years: Current evidence from randomized controlled trials
49. Breast cancer screening among women younger than age 50: A current assessment of the issues
50. Efficacy of breast cancer screening by age: New results from the Swedish two-county trial
51. What is the optimum interval between screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial
52. The Swedish two-county trial twenty years later
53. Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality
54. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian national breast screening study
55. The Canadian national breast screening study: A Canadian critique
56. Breast cancer in women: A population based study of contrasts in stage, survival, and surgery
57. Mammographic film density and detection of small breast cancers